Mice transgenic for simian immunodeficiency virus nef are immunologically compromised

Journal of Biomedical Science

Volumn 5, Issue 4, 1998, Pages 260-266

  Larsen, Nicholette B ^a   Kestler, Harry W ^b   Docherty, John J ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b Lorain County Community College   (United States)

Author keywords

Herpes simplex virus; IgG1; IgG2a; Nef; Simian immunodeficiency virus; Transgenic mice

Indexed keywords

NEF PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0031827420     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02255857     Document Type: Article

References (34)

1. Ahmad N, Venkatesan S. Nef protein of HIV-1 is a transcriptional repressor or HIV-1 LTR. Science 241:1481-1485;1988.
2. Aiken C, Konner J, Landau N, Lenburg M, Trono D. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853-864;1994.
3. CDC. Mortality attributable to HIV infection among persons aged 25-44 years - United States. MMWR 45:121-125;1996.
4. Chowers M, Spina C, Kwoh T, Fitch N, Richman D, Guatelli J. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J Virol 68:2906-2914;1994.
5. Chirmule N, Oyiazu N, Saxinger C, Pahwa S. Nef protein of HTV-1 has B-cell stimulatory activity. AIDS 8:733-734;1994.
6. Daniel M, Kirchhoff F, Czajak S, Sehgal P, Desrosiers R. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941;1992.
7. Darville J, BIyth W. Neutralizing antibody in mice with primary and recurrent herpes simplex virus infection. Arch Virol 71:303-310; 1982.
8. Deacon N, Tyskin A, Solomon A, Smith K, Ludford-Menting M. et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991;1995.
9. Docherty J, Lohse M. Dellaria M, Naugle F, Mason C, Knerr R, McDermott H, Mundon F, Zimmerroan D. Incidence of herpes simplex virus types 1 and 2 in penile lesions of college men. J Med Virol 13:163-170;1984.
10. Garcia J, Miller A. Serine phosphorylationindependent downregulation of cell-surface CD4 by nef. Nature 350:508-511;1991.
11. Giorgi J, Hultin L, Desrosiers R. The immunopathogenesis of retroviral diseases: No immunophenotypic alterations in T, B, and NK cell subsets in SIVmac239-challenged rhesus macaques protected by SIV delta nef vaccination. J Med Primatol 25:186-191;1996.
12. Gordon J, Ruddle F. Integration and stable germ line transmission of genes injected into mouse pronuclei. Science 214:1244-1246; 1981.
13. Kestler H, Kodama T, Ringler D, Marthas M, Pedersen M, et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248:1109-1112; 1990.
14. Kestler H, Ringler D, Mon K, Panicali D, Sehgal P, Daniel M, Desrosiers R. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65: 651-662;1991.
15. Kirchhoff F, Greenough T, Brettler D, Sullivan J, Desrosiers R. Brief report: Absence of intact nef sequences in a long-term survivor with nonprogressive HTV-1 infection. N Engl J Med 332:228-232;1995.
16. Le Gall S, Prevost M, Heard J, Schwartz O. Human immunodeficiency virus type 1 Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virus infectivity. Virology 229:295-301;1997.
17. Lindemann D, Wilhelm R, Renard P, Althage A, Zinkemagl R. Mous J. Severe immunodeficiency associated with a human immunodeficiency virus-1 nef/3′-long terminal repeat transgene. J Exp Med 179:797-807;1994.
18. Luciw PA, Cheng-Mayer C, Levy JA. Mutational analysis of the human immunodeficiency virus: The orf-B region down-regulates virus replication. Proc Natl Acad Sci USA 84:1434-1438;1987.
19. Luria S, Chambers I, Berg P. Expression of the type human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc Natl Acad Sci USA 88:5326-5330;1991.
20. Mangasarian A, Foti M, Aiken C, Chin D, Carpentier J, Trono D. The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. Immunity 6:67-77;1997.
21. Miller M, Warmerdam M, Gaston I, Greene W, Feinberg M. The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 179: 101-113;1994.
22. Masur H, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: Initial manifestation of cellular immune dysfunction. N Engl J Med 305:1431-1438;1981.
23. Myers G, Korber B, Berzofsky JA, Smith RF, Paualakis GN. Human retroviruses and AIDS: A complication and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory; 1991.
24. Niederman T, Garcia J, Hastings W, Luria S, Ratner L. Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction of human T cells. J Virol 66:6213-6219; 1992.
25. Quinn T. Global burden of the HIV pandemic. Lancet 348:99-106;1996.
26. Roost H, Charan S, Gobet R, Ruedi E, Hengartner H, Althage A, Zingernagel R. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus. Eur J Immunol 18:511-518;1988.
27. Rose N, deMacaro E, Fahey J, Friedman H, Penn G, eds. Manual of Clinical Laboratory Immunology, 4th ed. Washington, DC: American Society for Microbiology, pp 2-9.
28. Schmid DS, Rouse BT. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: Differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors. J Immunol 131:479-484; 1983.
29. Schwanz O, Marechal V, Le Gall S, Lemonnier F, Heard J. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2:338-342; 1996.
30. Simmons A, Nash A. Role of antibody in primary and recurrent herpes simplex virus infection. J Virol 53:944-948;1985.
31. Skowronski J, Parks D, Marian i R. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J 12:703-713;1993.
32. Spina C, Kwoh T, Chowers M, Guatelli J, Richman D. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary CD4 lymphocytes. J Exp Med 179;115-123;1994.
33. Switzer WM, Wiktor S, Soriano V, Silva-Graca A, Mansinho K, Coulibaly IM, Ekpini E, Greenberg AE, Folds TMT Heneine W. Evidence of Nef truncation in human immunodeficiency virus type 2 infection. J Infect Dis 177(1):65-71;1998.
34. Taketo M, et al. FVB/N: An inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci USA 88:2065-2069;1991.